Menu
Recruiting NCT06899048

The Association Between Residual Neuromuscular Block Risk Prediction Score and the Train-of-Four Ratio

Observational Muscle Relaxants

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: residual neuromuscular block risk prediction score.
Who it may be relevant to
Registry conditions: Muscle Relaxants. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Residual Paralysis in the Post Anesthesia Care Unit: The Association Between Residual Neuromuscular Block Risk Prediction Score and the Train-of-Four Ratio. A Prospective Single-Center Open-Label Cohort Study

Overview

evaluate the degree of association, and the predictive accuracy of the REPS (as a predictive tool) compared with the TOFr as a quantitative assessment tool for (rNMB) in surgical patients in the early postoperative phase. The TOFr will be measured at 0, 15, 30, 45, and 60 min after extubation.

Interventions

  • Diagnostic test residual neuromuscular block risk prediction score
    it is a clinical tool designed to estimate the likelihood of residual neuromuxcular blockade in postoperative patients

Primary outcome measures

  • correlation between residual neuromuscular block risk prediction score and train of four [Time frame: 1 hour]

Eligibility criteria

Inclusion criteria

  • Age group 18-65 years old
  • Both genders
  • Patients with American Society of Anesthesiologist physical status classification of 1 or 2.

Exclusion criteria

  • Patients who are less than 18 years old or more than 65 years old.
  • Patients with planned scheduled recovery in the intensive care unit or if more than 10 minutes had elapsed since tracheal extubation until NMB monitoring at the PACU.
  • Patients on medications that interfere with muscle activity.
  • Known allergy to neuromuscular blocking agents.
  • Pregnancy or suspected pregnancy.
  • Neuro-muscular diseases.
  • Patients refusing to participate in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Egypt · 1 center
  • Assiut University Hospitals — Asyut

Identifiers

NCT: NCT06899048 · 04-2025-201158

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗